Jeffrey JaySenior Managing Director at Great Point Partners
Dr. Jay has more than 30 years of private equity experience. Prior to founding Great Point Partners in 2003, he was for 11 years a General Partner and the head of the health care group at J. H. Whitney & Co., an investment firm with over $6 billion in private equity, subordinated debt and hedge funds under management.
Dr. Jay has led numerous private equity investments and has been the chairman or a member of the boards of numerous companies including AdvancePCS (ADVP), American Surgical Professionals, Biotronic NeuroNetwork, Clinical Supplies Management, Concentra Managed Care (CCMC), Cytovance Biologics, Eon Labs (ELAB), which was acquired by Novartis, Equian, MaSTherCell, Softbox Systems, Symbion (SYMB), United Claim Solutions and U.S. Bioservices.
Dr. Jay received his B.A. magna cum laude and his M.D. with honors from the six-year B.A./M.D. program at the Boston University School of Medicine and an M.B.A. from the Harvard Business School. He is on the Dean’s Board of Advisors at the Boston University School of Medicine, the Harvard Business School Health Care Advisory Board and the Harvard University Committee on University Resources.